IL-23 Inhibitors for Psoriatic Arthritis

(MedPage Today) -- At this year's American College of Rheumatology (ACR) annual meeting, new data were presented on interleukin (IL)-23-targeting treatments for psoriatic arthritis (PsA).
In this second of three exclusive episodes, MedPage Today...